NYSE Arca · PMI
Picard Medical, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for PMI: Nov 13, 2026
Picard Medical, Inc. Common Stock is estimated to report earnings on 11/13/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-1.5. The reported EPS for the same quarter last year was $-9.5.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-1.50 | $-1.50 | $-1.50 | 1 |
| Dec 2026 | $-1.50 | $-1.50 | $-1.50 | 1 |
| Mar 2027 | $-15.00 | $-15.00 | $-15.00 | 1 |
| Jun 2027 | $-1.00 | $-1.00 | $-1.00 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · Fintel- RTTNews · Aug 24, 10:07 PM EDT5 After-Hours Healthcare Gainers: AMIX, PMI, TENX, KURA, NEPH(RTTNews) – The after-hours gainers on Monday included Autonomix Medical, following its recent reverse stock split; Picard Medical, which reported encouraging Q2 results recently; and Tenax Therapeutics, now showing signs of recovery after plunging 90% earlier this month, among o
- RTTNews · Aug 24, 3:09 PM EDTBiotech Gainers: PMI Revenue Growth, SDOT Earnings Surge, CAPR FDA Update, GRI Data Drive Gains(RTTNews) – Today's top gainers in the biotech and healthcare space include Picard Medical, following strong second-quarter revenue growth; Sadot Group, after a sharp surge in net income; Capricor Therapeutics, following an FDA review extension for deramiocel; GRI Bio, after Phas
- RTTNews · Aug 24, 2:35 PM EDTPicard Medical Stock Jumps 40% After Q2 Revenue Rises 39%; Loss Narrows(RTTNews) – Picard Medical, Inc. (PMI) shares were trading significantly higher by around 40% in and after the premarket session, following the company's second-quarter 2026 financial results, which showed strong revenue growth, improved gross profitability and a narrower net los
- Zacks · Aug 13, 5:15 PM EDTDare Bioscience, Inc. (DARE) Reports Q2 Loss, Beats Revenue EstimatesDare Bioscience (DARE) delivered earnings and revenue surprises of +39.39% and +1,775.46%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Jul 22, 4:15 AM EDTPicard Announces 1-for-50 Reverse Stock Split For NYSE American Listing Compliance; Shares Plunge(RTTNews) – Picard Medical, Inc. (PMI), the parent company of SynCardia Systems, LLC, announced that its board has approved the implementation of a 1-for-50 reverse stock split of Picard Medical's issued and outstanding common stock. The reverse stock split is intended to support
- RTTNews · Jun 3, 9:10 AM EDTPre-Market Movers: PMI, CNTB, RNAZ Chart The Course(RTTNews) – Pre-market trading is offering an early glimpse into biotech stocks likely to attract investor attention this Wednesday.
- RTTNews · Jun 2, 10:11 PM EDTTop Biotech Gainers: PMI Advances Artificial Heart, CUE Makes Board Changes, CING Up Despite CRL(RTTNews) – Tuesday's top gainers in the healthcare sector included Bluejay Diagnostics, which inked a strategic partnership with Argonaut; Picard Medical, which is advancing its next-generation Emperor Total Artificial Heart; and Cingulate, which rallied despite a regulatory set
- RTTNews · Jun 2, 9:30 AM EDTPicard Medical Reports Successful In Vivo Implant Studies For Emperor TAH; Stock Up(RTTNews) – Picard Medical, Inc. (PMI), a medical device manufacturer, announced the successful completion of an acute in vivo implant study series using the company's Emperor Total Artificial Heart (Emperor TAH) Platform at the University of Arizona and Banner University Medical
- RTTNews · Jun 2, 8:41 AM EDTPre-Market Movers: BJDX, PMI, SBFM Drive Momentum(RTTNews) – Biotech stocks are showing strong pre-market moves this Tuesday, hinting at possible breakout setups.
- RTTNews · May 21, 10:55 AM EDTPicard Medical Plunges On Wider Q1 Net Loss Despite Revenue Growth(RTTNews) – Picard Medical, Inc. (PMI), the parent company of SynCardia Systems, LLC, the maker of the world's first and only commercially approved Total Artificial Heart or TAH, reported financial results for the first quarter ended March 31, 2026, reflecting a wider net loss de
- Fintel · May 18, 9:53 AM EDTHC Wainwright & Co. Initiates Coverage of Picard Medical (PMI) with Neutral RecommendationFintel reports that on May 18, 2026, HC Wainwright & Co. initiated coverage of Picard Medical (NYSEAM:PMI) with a Neutral recommendation. What is the Fund Sentiment?
- Zacks · Apr 20, 10:16 AM EDTPhilip Morris' IQOS Retains FDA Modified-Risk AuthorizationPhilip Morris wins renewed FDA backing for IQOS, keeping its modified-risk claims alive as the company accelerates its shift beyond cigarettes.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Picard Medical, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.